COVID-19 and Your Health
It’s important for those suffering from allergy, asthma and other respiratory issues to be vigilant about following treatment instructions and their providers’ directions on their care plans.
Take medication/treatment as directed, and follow good health hygiene and public health recommendations as the situation continues to evolve. We care about your health and are here to answer questions regarding your care — (866) 793-1680, ext. 512.
Allergy Related Health Conditions
A key benefit of sublingual immunotherapy treatment is its safety, allowing those who aren’t candidates for — or can’t comply with other treatment — to have the chance to change their allergic disease. Learn how the La Crosse Method™ Protocol addresses a wide variety of allergies and related conditions:
La Crosse Method™ Protocol
Through the La Crosse Method Protocol, providers and patients have access to a fully customizable, safe, and effective method to treat the full spectrum of allergy — from moderately allergic sufferers to those with debilitating and ultimately life-threatening allergies.
Used clinically since 1970, the evidence-based La Crosse Method is the most widely-used published SLIT protocol in the U.S. with more than 250,000 patients treated.
As a family of protocols, the La Crosse Method offers flexible options to treat each patient uniquely based on history, symptoms, and the number and severity of allergies in their unique allergic “fingerprint.”
La Crosse Method Protocol outcomes have been validated through the Validation Institute, an independent team of population health scientists and bio-statisticians who provide objective review to validate performance in healthcare. For more information, visit validationinstitute.com.
Allergychoices works as an extension of your practice, bringing seamless support and implementation expertise so providers and staff can focus on patient care. Our services complement your practice’s capabilities, helping you build a successful program that can change allergic diseases:
What Sets Allergychoices Apart?
Protocol with 50+ years
of Clinical Use
97% Patients Reported
96% Patients Reported